Gut Robert
Director at QURE
- Sold, on record
- $5M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Jun 11, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- QUREuniQure N.V.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale QURENo planJun 20, 2025 2025
Sold 3,336 shares at $14.45 ($48k)
Gut Robert, Director
No 10b5-1 planSold 5.5% of holdings ($870k position)56,879 shares leftFiling
- 2 Form 144 notice QURENoticeNov 6, 2025 +139 days
Filed to sell 31,434 shares ($819k)
Gut Robert, Director
10b5-1 planFiling
- 3 Form 4 sale QURERoutineNov 6, 2025 same day
Sold 31,434 shares at $27.26 ($857k)
Gut Robert, Director
10b5-1 planSold 43.9% of holdings ($2M position)40,145 shares leftFollows a Form 144Filing
- 4 Form 144 notice QURENoticeJan 12, 2026 +67 days
Filed to sell 25,613 shares ($677k)
Gut Robert, Director
10b5-1 plan7.3x usual sizeFiling
- 5 Form 4 sale QUREUnusualJan 12, 2026 same day
Sold 25,613 shares at $24.62 ($630k)
Gut Robert, Director
10b5-1 planSold 44.2% of holdings ($1.4M position)32,342 shares left7.3x usual sizeFollows a Form 144Filing
- 6 Form 144 notice QURENoticeJun 10, 2026 +149 days
Filed to sell 7,552 shares ($197k)
Gut Robert, Director
10b5-1 plan0.5x usual sizeFiling
- 7 Form 144 notice QURENoticeJun 11, 2026 +1 day
Filed to sell 2,726 shares ($74k)
Gut Robert, Director
No 10b5-1 plan0.2x usual sizeFiling
- 8 Form 4 sale QURERoutineJun 11, 2026 same day
Sold 10,278 shares at $26.32 ($270k)
Gut Robert, Director
10b5-1 planSold 24.2% of holdings ($1.1M position)32,259 shares left0.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 12, 2026 | QURE | Director | Form 4 sale | 10,278 | $270k | 24.2% | Routine | SEC |
| Jun 11, 2026 | Jun 11, 2026 | QURE | Director | Form 144 notice | 2,726 | $74k | Notice | SEC | |
| Jun 10, 2026 | Jun 10, 2026 | QURE | Director | Form 144 notice | 7,552 | $197k | Notice | SEC | |
| Jan 12, 2026 | Jan 14, 2026 | QURE | Director | Form 4 sale | 25,613 | $630k | 44.2% | Unusual | SEC |
| Jan 12, 2026 | Jan 12, 2026 | QURE | Director | Form 144 notice | 25,613 | $677k | Notice | SEC | |
| Nov 6, 2025 | Nov 10, 2025 | QURE | Director | Form 4 sale | 31,434 | $857k | 43.9% | Routine | SEC |
| Nov 6, 2025 | Nov 6, 2025 | QURE | Director | Form 144 notice | 31,434 | $819k | Notice | SEC | |
| Jun 20, 2025 | Jun 24, 2025 | QURE | Director | Form 4 sale | 3,336 | $48k | 5.5% | No plan | SEC |
| Jun 13, 2024 | Jun 17, 2024 | QURE | Director | Form 4 sale | 3,504 | $18k | 7.4% | No plan | SEC |
| Jun 16, 2023 | Jun 20, 2023 | QURE | Director | Form 4 sale | 3,228 | $61k | 6.3% | No plan | SEC |
| Feb 28, 2023 | Mar 1, 2023 | QURE | Director | Form 4 sale | 1,968 | $41k | 4.5% | Plan not stated | SEC |
| Feb 28, 2022 | Mar 2, 2022 | QURE | Director | Form 4 sale | 1,602 | $27k | 4.4% | Plan not stated | SEC |
| Jan 26, 2022 | Jan 28, 2022 | QURE | Director | Form 4 sale | 2,348 | $43k | 6.3% | Plan not stated | SEC |
| Sep 21, 2021 | Sep 22, 2021 | QURE | Director | Form 4 sale | 4,500 | $165k | 10.7% | Plan not stated | SEC |
| Mar 2, 2021 | Mar 4, 2021 | QURE | Director | Form 4 sale | 1,300 | $48k | 3.0% | Plan not stated | SEC |
| Jan 26, 2021 | Jan 28, 2021 | QURE | Chief Medical Officer | Form 4 sale | 604 | $24k | 1.5% | Plan not stated | SEC |
| Sep 21, 2020 | Sep 22, 2020 | QURE | Chief Medical Officer | Form 4 sale | 4,352 | $170k | 9.5% | Plan not stated | SEC |
| Jun 23, 2020 | Jun 24, 2020 | QURE | Chief Medical Officer | Form 4 sale | 26,875 | $1.9M | 36.9% | Unusual | SEC |
| Jan 28, 2020 | Jan 29, 2020 | QURE | Chief Medical Officer | Form 4 sale | 7,493 | $451k | 21.2% | Plan not stated | SEC |
| Sep 19, 2019 | Sep 20, 2019 | QURE | Chief Medical Officer | Form 4 sale | 4,769 | $225k | 11.9% | Plan not stated | SEC |